- Investing Ideas
- /
- U.S. Undervalued Stocks Based On Cash Flows
U.S. Undervalued Stocks Based On Cash Flows
Results
161
19 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
161 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARRY | US$6.90 | 4.4% | -47.6% | US$1.0b | US$10.28 | PS1.1x | E64.9% | n/a | Capital Goods | ||
SASR | US$32.99 | -2.3% | 50.6% | US$1.5b | US$37.00 | PB1x | E67.3% | 4.1% | Banks | ||
SEI New | US$29.34 | 7.6% | 280.1% | US$2.0b | US$39.00 | PE86.2x | E83.0% | 1.6% | Energy | ||
NWBI | US$12.65 | -3.4% | 10.0% | US$1.6b | US$13.88 | PB1x | E33.6% | 6.3% | Banks | ||
LPRO | US$5.44 | -5.1% | -31.9% | US$660.0m | US$7.38 | PE141.6x | E67.5% | n/a | Diversified Financials | ||
LMB | US$83.35 | -8.1% | 106.1% | US$972.6m | US$115.33 | PE35.8x | E21.0% | n/a | Capital Goods | ||
HAE New | US$63.45 | 1.9% | -15.3% | US$3.2b | US$96.80 | PE24.5x | E21.1% | n/a | Healthcare | ||
ONB | US$23.97 | 0.5% | 44.1% | US$7.8b | US$27.72 | PB1.3x | E33.3% | 2.3% | Banks | ||
INCY | US$71.38 | 2.0% | 17.2% | US$13.6b | US$78.26 | PE423.5x | E22.3% | n/a | Pharmaceuticals & Biotech | ||
GABC | US$39.82 | -1.8% | 24.7% | US$1.2b | US$48.17 | PB1.7x | E23.4% | 2.9% | Banks | ||
CTRE New | US$25.62 | -3.4% | 11.1% | US$4.9b | US$31.60 | PB1.7x | E36.1% | 4.5% | Real Estate | ||
KBR | US$50.74 | -3.3% | -14.4% | US$6.9b | US$74.50 | PE21.2x | E22.9% | 1.2% | Commercial Services | ||
VRRM | US$26.13 | -1.7% | 20.7% | US$4.4b | US$29.00 | PE42.6x | E23.1% | n/a | Commercial Services | ||
AMD | US$114.17 | 2.1% | -37.2% | US$185.9b | US$148.34 | PE112.7x | E32.0% | n/a | Semiconductors | ||
BRKL | US$11.89 | -3.5% | 21.9% | US$1.1b | US$14.94 | PB0.9x | E91.4% | 4.5% | Banks | ||
ALB New | US$82.51 | 4.1% | -30.2% | US$9.8b | US$102.05 | PS1.8x | E57.0% | 2.0% | Materials | ||
DV | US$22.35 | -2.9% | -47.2% | US$3.8b | US$22.95 | PE57.3x | E21.3% | n/a | Software | ||
AGX | US$142.54 | -3.8% | 207.6% | US$2.0b | US$150.00 | PE29.3x | E21.2% | 1.1% | Capital Goods | ||
ATAT | US$31.92 | 7.9% | 64.5% | US$4.4b | US$34.14 | PE27.4x | E25.6% | 1.4% | Consumer Services | ||
CDRE | US$34.95 | -2.1% | -2.6% | US$1.4b | US$43.67 | PE43.3x | E30.1% | 1.0% | Capital Goods | ||
NTNX | US$72.09 | 1.8% | 23.6% | US$19.3b | US$81.91 | PS8.7x | E92.0% | n/a | Software | ||
FXNC | US$25.40 | -1.7% | 38.7% | US$231.7m | US$27.00 | PB1.4x | E46.0% | 2.4% | Banks | ||
ABBV | US$200.88 | 3.8% | 13.7% | US$348.4b | US$204.90 | PE83.7x | E25.3% | 3.3% | Pharmaceuticals & Biotech | ||
BHLB | US$28.61 | -3.3% | 29.9% | US$1.4b | US$34.55 | PB1.1x | E84.9% | 2.5% | Banks |